A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

Clinical trial NCT01277666 · COMPLETED

Trial details

NCT number: NCT01277666
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2010-12-20
Primary completion: 2013-07-11
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.